. 2011 Jun 28;12:29. doi: 10.1186/1471-2369-12-29

Table 2.

Age-gender standardized baseline demographics and laboratory results accordings to eGFR in the entire cohort (n = 1,363)

eGFR Characteristics	≥90 mL/min/1.73 m², n = 564	60-89 mL/min/1.73 m², n = 443	30-59 mL/min/1.73 m², n = 265	15-29 mL/min/1.73 m², n = 91	p-value
Age, years	50.1 ± 13.8	57.3 ± 13.8	59.3 ± 13.7	59.4 ± 14.6	0.0001
T¹⁾	a	b, c	c	c
Sex,%
Males	46	48.3	54.3	56
Females	54	51.7	45.7	44
Diabetes,%	52.8	45.1	32.8	29.4
Hypertension,%	10.1	12.1	23.3	21.2
Measurements
Urine protein, mg/day	572 ± 1,871	744 ± 2,366	1,231 ± 2,236	2,050 ± 3047	0.0001
T¹⁾	a	a, b	b	c
WBC, mm³	7,420 ± 3,116	7,534 ± 3,112	7,940 ± 3,003	7,909 ± 2,967	0.252
Hb, g/dL	12.5 ± 1.7	12.5 ± 1.7	11.6 ± 1.9	10.8 ± 1.8	0.0001
T¹⁾	a	a	b	c
Platelet, mm³	276,222 ± 103,955	259,255 ± 92,563	250,831 ± 96,831	235,755 ± 87,964	0.002
T¹⁾	a	a, b	a, b	b
Protein, g/dL	6.7 ± 3.3	6.6 ± 0.9	6.7 ± 3.8	6.3 ± 0.8	0.447
Albumin, g/dL	3.8 ± 0.7	3.8 ± 0.6	3.6 ± 0.7	3.5 ± 0.6	0.0001
T¹⁾	a	a	a, b	b
Total cholesterol, mg/dL	204 ± 93	208 ± 71	207 ± 87	205 ± 72	0.215
LDL Cholesterol, mg/dL	126 ± 55	113 ± 44	109 ± 34	112 ± 40	0.103
HDL cholesterol, mg/dL	46 ± 16	45 ± 16	42 ± 14	40 ± 12	0.001
T¹⁾	a	a, b	b, c	c
Triglycerides, mg/dL	170 ± 360	151 ± 127	155 ± 95	180 ± 192	0.657
AST, IU/L	29 ± 27	29 ± 20	27 ± 16	29 ± 38	0.108
ALT, IU/L	28 ± 25	28 ± 23	24 ± 20	26 ± 47	0.197
Fasting blood glucose, mg/dL	153 ± 81	142 ± 74	127 ± 62	127 ± 69	0.0001
T¹⁾	a	a, b	b	b
BUN, mg/dL	12.5 ± 4.5	16.1 ± 5.6	24.3 ± 9.4	38.1 ± 15.5	0.0001
T¹⁾	a	a	b	c
Creatinine, mg/dL	0.71 ± 0.13	0.96 ± 0.16	1.51 ± 0.33	2.86 ± 0.69	0.0001
T¹⁾	a	b	c	d
Total Bilirubin, mg/dL	0.77 ± 0.22	0.76 ± 0.21	0.72 ± 0.22	0.67 ± 0.21	0.0001
T¹⁾	a, b	a, b	b, c	c
Direct Bilirubin, mg/dL	0.31 ± 0.09	0.30 ± 0.09	0.30 ± 0.10	0.28 ± 0.09	0.222

1) The same letters indicate non-significant difference between groups based on Turey's multiple comparison test